Not a good buy right now for an impatient investor: the stock is in a sharp breakdown (-13.45% today and additional -6.72% pre-market), with momentum still deteriorating.
Oversold (RSI_6 ~14) can produce short bounces, but there is no proprietary buy signal (AI Stock Picker/SwingMax) to support taking immediate dip-buy risk.
Best interpretation of current setup: avoid new longs / exit if already in, until price reclaims key levels and momentum stabilizes.
MACD: Histogram -0.134 and negatively expanding => bearish momentum is strengthening, not bottoming.
RSI: RSI_6 at 14.361 signals extreme oversold; this increases odds of a short-term bounce but does not confirm a reversal.
Levels: Pivot 2.845 is far above current price (2.08), showing the stock is trading below its key balance point.
Support: S2 2.019 (near-term line in the sand); a breakdown below this can accelerate downside.
Resistance: S1 2.334 (now overhead resistance), then Pivot 2.845.
Pattern-based projection (similar candlesticks): next day -0.34%, next week +2.02%, next month +11.51% (possible rebound), but near-term risk remains elevated.
Key support is very close (S2 2.019); losing it could lead to another leg down.
No notable hedge fund or insider accumulation signals (both neutral), reducing confidence in a near-term floor.
No identifiable event-driven catalyst from news to justify immediate re-rating higher.
Financial Performance
Latest quarter: 2024/Q1.
Revenue: reported as 0 (0.00% YoY) — does not support a fundamental growth narrative based on the provided snapshot.
Net income: 268,671 (0.00% YoY) while EPS is -0.02 — mixed quality/consistency signals from the snapshot.
Gross margin: 6.49 (0.00% YoY) — low margin profile based on provided data.
Overall from provided numbers: no clear accelerating growth trend to counter the current bearish price action.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating / price target change data provided, so there is no visible Wall Street upgrade/downgrade trend to lean on.
Practical pros view (implied): none evidenced in the dataset.
Practical cons view (implied): without supportive coverage/targets and with price in a breakdown, institutional/Street conviction is not apparent.
Politicians/Congress: No recent congress trading data available (no signal from influential-figure trading).
Wall Street analysts forecast MKDW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MKDW is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast MKDW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MKDW is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
